A citation-based method for searching scientific literature

Lena Gaissmaier, Petros Christopoulos. Respiration 2020
Times Cited: 11







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breaking Bottlenecks for the TCR Therapy of Cancer.
Lena Gaissmaier, Mariam Elshiaty, Petros Christopoulos. Cells 2020
24
54

Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Petros Christopoulos, Marc A Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jens Kollmeier, Volker Baum, Thomas Muley, Philipp A Schnabel, Helge Bischoff,[...]. Lung Cancer 2018
15
36

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt,[...]. Int J Cancer 2019
60
36

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. J Clin Oncol 2021
164
36

Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231.
J M Ellis, V Henson, R Slack, J Ng, R J Hartzman, C Katovich Hurley. Hum Immunol 2000
105
27

TRUCKs: the fourth generation of CARs.
Markus Chmielewski, Hinrich Abken. Expert Opin Biol Ther 2015
319
27

Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL.
Petros Christopoulos, Dietmar Pfeifer, Kilian Bartholomé, Marie Follo, Jens Timmer, Paul Fisch, Hendrik Veelken. Blood 2011
86
27

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors.
Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke Winter, Felix J Herth, Thomas Muley, Stephan Liersch, Helge Bischoff,[...]. Cancers (Basel) 2020
29
27

Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
18

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein,[...]. Nat Med 2015
549
18

Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
Amaia Martinez-Usatorre, Santiago J Carmona, Céline Godfroid, Céline Yacoub Maroun, Sara Labiano, Pedro Romero. Front Immunol 2020
17
18

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F de Miranda, Cheri P Goodall, Tiffany C Blair, Bernard A Fox, Jason E McDermott,[...]. Nat Commun 2018
377
18

Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.
Karen M Kaluza, Timothy Kottke, Rosa Maria Diaz, Diana Rommelfanger, Jill Thompson, Richard Vile. Hum Gene Ther 2012
31
18

Proteomics. Tissue-based map of the human proteome.
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
18

Chimeric antigen receptor T cell persistence and memory cell formation.
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
98
18

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, Aaron P Rapoport, Bruce L Levine, Lyndsey Emery, Leslie Litzky, Adam Bagg, Beatriz M Carreno, Patrick J Cimino,[...]. Blood 2013
720
18

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.
Maria R Parkhurst, James C Yang, Russell C Langan, Mark E Dudley, Debbie-Ann N Nathan, Steven A Feldman, Jeremy L Davis, Richard A Morgan, Maria J Merino, Richard M Sherry,[...]. Mol Ther 2011
648
18

Reprogramming human T cell function and specificity with non-viral genome targeting.
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P Jonathan Li, Joseph Hiatt, Justin Saco, Paige Krystofinski, Han Li,[...]. Nature 2018
380
18


Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Laura A Johnson, Richard A Morgan, Mark E Dudley, Lydie Cassard, James C Yang, Marybeth S Hughes, Udai S Kammula, Richard E Royal, Richard M Sherry, John R Wunderlich,[...]. Blood 2009
997
18

NK cells specifically TCR-dressed to kill cancer cells.
Nadia Mensali, Pierre Dillard, Michael Hebeisen, Susanne Lorenz, Theodossis Theodossiou, Marit Renée Myhre, Anne Fåne, Gustav Gaudernack, Gunnar Kvalheim, June Helen Myklebust,[...]. EBioMedicine 2019
40
18

Engineered T Cell Therapy for Cancer in the Clinic.
Lijun Zhao, Yu J Cao. Front Immunol 2019
165
18

CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
562
18

Biotechnologies to tackle the challenge of neoantigen identification.
Marion Arnaud, Margaux Duchamp, Sara Bobisse, Philippe Renaud, George Coukos, Alexandre Harari. Curr Opin Biotechnol 2020
17
18

An immunogenic personal neoantigen vaccine for patients with melanoma.
Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter,[...]. Nature 2017
18

Acquired T-Cell Immunodeficiency in Thymoma Patients.
Petros Christopoulos, Paul Fisch. Crit Rev Immunol 2016
13
18

Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
Ronny Ben-Avi, Ronit Farhi, Alon Ben-Nun, Marina Gorodner, Eyal Greenberg, Gal Markel, Jacob Schachter, Orit Itzhaki, Michal J Besser. Cancer Immunol Immunother 2018
37
18

Tumor Antigen Escape from CAR T-cell Therapy.
Robbie G Majzner, Crystal L Mackall. Cancer Discov 2018
395
18

Induction of neoantigen-reactive T cells from healthy donors.
Muhammad Ali, Zsofia Foldvari, Eirini Giannakopoulou, Maxi-Lu Böschen, Erlend Strønen, Weiwen Yang, Mireille Toebes, Benjamin Schubert, Oliver Kohlbacher, Ton N Schumacher,[...]. Nat Protoc 2019
55
18

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Jamshid Hadjati. Front Immunol 2020
40
18

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.
Steven A Rosenberg, James C Yang, Richard M Sherry, Udai S Kammula, Marybeth S Hughes, Giao Q Phan, Deborah E Citrin, Nicholas P Restifo, Paul F Robbins, John R Wunderlich,[...]. Clin Cancer Res 2011
18

Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma.
Kendra C Foley, Michael I Nishimura, Tamson V Moore. Melanoma Res 2018
15
18

Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.
Edmund K Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S Wang, Veena Kapoor, Jarrod Predina, Daniel J Powell, James L Riley, Carl H June, Steven M Albelda. Clin Cancer Res 2011
361
18

A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression.
Petros Christopoulos, Elaine P Dopfer, Miroslav Malkovsky, Philipp R Esser, Hans-Eckart Schaefer, Alexander Marx, Sylvia Kock, Nicole Rupp, Myriam R Lorenz, Klaus Schwarz,[...]. J Immunol 2015
21
18


Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
Edward B Garon, Matthew D Hellmann, Naiyer A Rizvi, Enric Carcereny, Natasha B Leighl, Myung-Ju Ahn, Joseph Paul Eder, Ani S Balmanoukian, Charu Aggarwal, Leora Horn,[...]. J Clin Oncol 2019
515
18

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
18

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar, Simon J Ogrodnik, Florian Janke, Chiara Dalle Fratte, Tomasz Zemojtel,[...]. EBioMedicine 2020
24
18

Emerging Roles of ALK in Immunity and Insights for Immunotherapy.
Lan Wang, Vivian Wai Yan Lui. Cancers (Basel) 2020
8
25

ALK inhibitors and checkpoint blockade: a cautionary tale of mixing oil with water?
Malini Patel, Salma K Jabbour, Jyoti Malhotra. J Thorac Dis 2018
7
28

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
495
18

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Mark A Socinski, Robert M Jotte, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi,[...]. N Engl J Med 2018
18

The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.
Yangyang Xu, Bing Wan, Xi Chen, Ping Zhan, Yuan Zhao, Tianli Zhang, Hongbing Liu, Muhammad Zubair Afzal, Said Dermime, Steven N Hochwald,[...]. Transl Lung Cancer Res 2019
54
18

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
633
18

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
18

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
18

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
18


Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
18

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.